- Home
- CGTX vs EPSN Comparison
CGTX vs EPSN Comparison
Compare CGTX & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGTX | EPSN |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 132.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGTX | EPSN |
|---|---|---|
| Price | $1.54 | $4.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.88 | N/A |
| AVG Volume (30 Days) | ★ 938.2K | 125.8K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.47% |
| EPS Growth | N/A | ★ 11.33 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $45,709,605.00 |
| Revenue This Year | N/A | $41.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.09 |
| Revenue Growth | N/A | ★ 46.76 |
| 52 Week Low | $0.22 | $4.36 |
| 52 Week High | $3.83 | $8.50 |
Technical Indicators
Market Signals| Indicator | CGTX | EPSN |
|---|---|---|
| Relative Strength Index (RSI) | 46.12 | 39.92 |
| Support Level | $1.46 | $4.76 |
| Resistance Level | $1.61 | $5.09 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 27.03 | 1.82 |
Price Performance
Historical ComparisonAbout CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About EPSN Epsilon Energy Ltd.
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.